NYSEAMERICAN : IGC

IGC Pharma, Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 0.185 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 19.13M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

IGC Pharma, Inc. (IGC) reported revenue of 1.11M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year April - March; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue1.11M1.27M1.34M911.00K397.00K898.00K
Cost of Revenue595.00K652.00K612.00K469.00K203.00K785.00K
Gross Profit511.00K619.00K733.00K442.00K194.00K113.00K
Selling, General & Admin4.32M4.41M6.76M8.55M12.46M7.91M
Research & Development4.29M3.65M3.77M3.46M2.33M929.00K
Operating Expenses8.61M8.06M10.53M12.01M14.79M8.84M
Operating Income-8.10M-7.45M-9.80M-11.57M-14.60M-8.72M
Other Non Operating Income (Expenses)1.62M300.00K99.00K104.00K31.00K82.00K
EBT Excluding Unusual Items-6.47M-7.15M-9.70M-11.47M-14.56M-8.64M
Gain (Loss) on Sale of Investments-49.00K-169.00K
Gain (Loss) on Sale of Assets25.00K25.00K44.00K-39.00K
Asset Writedown1.00K-3.35M-833.00K
Other Unusual Items430.00K
Pretax Income-6.45M-7.12M-13.00M-11.51M-15.02M-8.81M
Earnings From Continuing Operations-6.45M-7.12M-13.00M-11.51M-15.02M-8.81M
Net Income-6.45M-7.12M-13.00M-11.51M-15.02M-8.81M
Net Income to Common-6.45M-7.12M-13.00M-11.51M-15.02M-8.81M
Shares Outstanding (Basic)82.69M76.52M58.84M52.58M49.99M41.96M
Shares Outstanding (Diluted)82.69M76.52M58.84M52.58M49.99M41.96M
EPS (Basic)-0.08-0.09-0.22-0.22-0.30-0.21
EPS (Diluted)-0.08-0.09-0.22-0.22-0.30-0.21
Free Cash Flow-5.63M-4.91M-5.34M-7.36M-7.70M-12.27M
Free Cash Flow Per Share-0.07-0.06-0.09-0.14-0.15-0.29
Gross Margin46.20%48.70%54.50%48.52%48.87%12.58%
Operating Margin-731.92%-585.84%-728.48%-1,270.14%-3,676.32%-971.49%
Profit Margin-582.82%-560.27%-966.54%-1,263.01%-3,782.37%-981.18%
Free Cash Flow Margin-508.68%-386.07%-396.80%-807.57%-1,939.04%-1,366.37%
EBITDA-7.52M-6.83M-9.16M-10.91M-13.94M-8.25M
D&A For EBITDA571.00K618.00K637.00K657.00K651.00K478.00K
EBIT-8.10M-7.45M-9.80M-11.57M-14.60M-8.72M

Balance sheet

Fiscal year April - March; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents1.10M405.00K1.20M3.20M10.46M14.55M
Short-Term Investments25.00K154.00K80.00K
Cash & Short-Term Investments1.13M405.00K1.20M3.35M10.46M14.63M
Accounts Receivable41.00K34.00K39.00K107.00K125.00K175.00K
Other Receivables20.00K43.00K52.00K24.00K472.00K45.00K
Receivables61.00K77.00K91.00K131.00K597.00K220.00K
Inventory658.00K1.36M1.54M2.65M3.55M7.18M
Prepaid Expenses130.00K342.00K115.00K262.00K166.00K160.00K
Other Current Assets25.00K712.00K761.00K72.00K340.00K1.33M
Total Current Assets2.00M2.90M3.71M6.47M15.11M23.52M
Property, Plant & Equipment2.19M3.32M3.89M8.54M9.87M11.33M
Long-Term Investments12.00K
Other Intangible Assets4.88M1.85M1.62M1.17M917.00K407.00K
Other Long-Term Assets672.00K681.00K688.00K1.00M937.00K603.00K
Total Assets9.74M8.75M9.90M17.18M26.83M35.87M
Accounts Payable628.00K883.00K773.00K530.00K981.00K476.00K
Accrued Expenses544.00K277.00K1.02M877.00K1.21M1.18M
Current Portion of Long-Term Debt3.00K304.00K
Current Portion of Leases9.00K94.00K124.00K133.00K123.00K90.00K
Other Current Liabilities333.00K1.00M419.00K358.00K122.00K316.00K
Total Current Liabilities1.51M2.26M2.34M1.90M2.44M2.37M
Long-Term Debt132.00K134.00K137.00K141.00K144.00K276.00K
Long-Term Leases5.00K10.00K84.00K207.00K341.00K405.00K
Pension & Post-Retirement Benefits16.00K20.00K21.00K16.00K15.00K
Total Liabilities1.65M2.42M2.58M2.27M2.94M3.06M
Common Stock135.77M130.57M124.41M118.97M116.02M109.72M
Retained Earnings-122.83M-120.74M-113.67M-100.67M-89.16M-74.14M
Comprehensive Income & Other-4.85M-3.50M-3.42M-3.39M-2.97M-2.77M
Total Common Equity8.09M6.33M7.32M14.91M23.89M32.80M
Shareholders' Equity8.09M6.33M7.32M14.91M23.89M32.80M
Total Liabilities & Equity9.74M8.75M9.90M17.18M26.83M35.87M
Total Debt146.00K238.00K345.00K481.00K611.00K1.07M
Net Cash (Debt)984.00K167.00K853.00K2.87M9.85M13.55M
Net Cash Per Share0.010.000.010.050.200.32
Filing Date Shares Outstanding92.87M83.89M75.64M53.08M51.74M48.33M
Total Common Shares Outstanding91.96M80.88M66.69M53.08M51.05M47.83M
Working Capital490.00K639.00K1.36M4.57M12.67M21.15M
Book Value Per Share0.090.080.110.280.470.69
Tangible Book Value3.21M4.48M5.71M13.74M22.98M32.40M
Tangible Book Value Per Share0.030.060.090.260.450.68
Land4.10M4.44M4.61M
Buildings1.50M2.34M2.30M2.30M2.81M3.82M
Machinery2.38M3.57M3.83M3.75M5.28M5.20M
Construction In Progress108.00K50.00K

Cash flow statement

Fiscal year April - March; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-6.45M-7.12M-13.00M-11.51M-15.02M-8.81M
Depreciation & Amortization571.00K618.00K637.00K657.00K651.00K478.00K
Loss (Gain) From Sale of Assets-25.00K-25.00K-44.00K39.00K
Asset Writedown & Restructuring Costs152.00K152.00K3.45M833.00K
Loss (Gain) From Sale of Investments49.00K169.00K
Stock-Based Compensation2.02M1.64M1.77M2.84M2.20M658.00K
Provision & Write-off of Bad Debts13.00K13.00K93.00K126.00K1.72M
Other Operating Activities-1.06M-430.00K
Change in Accounts Receivable-10.00K-8.00K-25.00K5.00K50.00K-42.00K
Change in Inventory167.00K180.00K1.01M897.00K1.93M-1.23M
Change in Accounts Payable-142.00K106.00K243.00K-451.00K504.00K-287.00K
Change in Other Net Operating Assets-777.00K-350.00K668.00K343.00K52.00K-1.73M
Operating Cash Flow-5.54M-4.79M-5.20M-7.05M-7.46M-10.80M
Capital Expenditures-82.00K-112.00K-138.00K-310.00K-236.00K-1.47M
Sale of Property, Plant & Equipment703.00K40.00K44.00K538.00K29.00K
Sale (Purchase) of Intangibles-636.00K-370.00K-377.00K-309.00K-535.00K-122.00K
Investment in Securities-25.00K154.00K-154.00K4.98M
Investing Cash Flow-40.00K-442.00K-317.00K-235.00K-742.00K3.39M
Long-Term Debt Issued530.00K
Total Debt Issued530.00K
Long-Term Debt Repaid-3.00K-3.00K-3.00K-3.00K
Total Debt Repaid-3.00K-3.00K-3.00K-3.00K-3.00K
Net Debt Issued (Repaid)-3.00K-3.00K-3.00K-3.00K-3.00K530.00K
Issuance of Common Stock5.11M4.45M3.53M103.00K4.14M14.16M
Financing Cash Flow5.11M4.45M3.52M100.00K4.14M14.69M
Foreign Exchange Rate Adjustments32.00K-7.00K-6.00K-82.00K-26.00K15.00K
Net Cash Flow-441.00K-793.00K-2.00M-7.26M-4.09M7.29M
Free Cash Flow-5.63M-4.91M-5.34M-7.36M-7.70M-12.27M
Free Cash Flow Margin-508.68%-386.07%-396.80%-807.57%-1,939.04%-1,366.37%
Free Cash Flow Per Share-0.07-0.06-0.09-0.14-0.15-0.29
Levered Free Cash Flow-2.52M-2.91M-3.17M-3.37M-2.47M-9.21M
Unlevered Free Cash Flow-2.52M-2.91M-3.17M-3.37M-2.47M-9.21M
Change in Working Capital-762.00K-72.00K1.89M794.00K2.54M-3.29M

Ratios

Fiscal year April - March; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization20.46M22.71M26.43M18.02M48.45M81.21M
Enterprise Value19.48M22.51M25.43M13.50M37.15M79.33M
Last Close Price0.180.280.400.340.951.79
Forward PE4.354.354.354.354.35
PS Ratio17.2917.8719.6519.78122.0390.43
PB Ratio2.103.593.611.212.032.48
P/TBV Ratio5.955.074.631.312.112.51
PEG Ratio2.262.262.262.262.26
EV/Sales Ratio16.4017.7118.9114.8293.5788.34
Debt / Equity Ratio0.020.040.050.030.030.03
Net Debt / Equity Ratio-0.12-0.03-0.12-0.19-0.41-0.41
Net Debt / EBITDA Ratio0.130.020.090.260.711.64
Net Debt / FCF Ratio0.170.030.160.391.281.10
Asset Turnover0.110.140.100.040.010.03
Inventory Turnover0.550.450.290.150.040.14
Quick Ratio0.790.210.551.834.536.27
Current Ratio1.321.281.583.416.199.93
Return on Equity (ROE)-83.34%-104.33%-116.95%-59.30%-52.97%-29.70%
Return on Assets (ROA)-50.31%-49.91%-45.23%-32.86%-29.10%-16.81%
Return on Capital Employed (ROCE)-98.40%-114.70%-129.60%-75.70%-59.80%-26.00%
Earnings Yield-39.39%-31.36%-49.20%-63.85%-31.00%-10.85%
FCF Yield-29.42%-21.61%-20.20%-40.83%-15.89%-15.11%
Buyback Yield / Dilution-19.49%-30.04%-11.91%-5.17%-19.13%-6.26%